Shangya Technology Co., Ltd. (6130) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shangya Technology Co., Ltd. (6130:TWSE), powered by AI.

Current Price
$24.65
Sector
Healthcare
What is the Shangya Technology Co., Ltd. stock price forecast?

Shangya Technology Co., Ltd. is currently trading at $24.65. View real-time AI analysis on Alpha Lenz.

What is Shangya Technology Co., Ltd. insider trading activity?

View the latest insider trading data for Shangya Technology Co., Ltd. on Alpha Lenz.

What is Shangya Technology Co., Ltd.'s P/E ratio?

View Shangya Technology Co., Ltd.'s valuation metrics on Alpha Lenz.

Shangya Technology Co., Ltd.

TWSE · 6130
NT$24.65-0.10(-0.40%)
Ask about Shangya Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Shangya Technology Co., Ltd.'s ROE is -13.0%. Explore profitability and growth together.

Ask for details

Company Overview

Shangya Technology Co., Ltd. is a health technology enterprise specializing in the development and distribution of biomedical products. Established in 1994 and headquartered in Taipei, the company operates across several segments, including Operation & Management, Business Development, and Food & Beverage. Within its Operation & Management division, Shangya provides education and training services, equipment leasing, medical cosmetology solutions, and consultancy for Chinese medicine clinics. The Business Development segment focuses on the sales of Chinese medicine and medical cosmetic materials, supporting healthcare distributors and providers. Its Food & Beverage segment is engaged in the production and retailing of specialty foods, adding further diversity to its portfolio. Through these activities, Shangya Technology plays a multifaceted role in Taiwan’s biotechnology and healthcare sectors, responding to growing demand for integrated health services and products. The company’s operations highlight its involvement in both the scientific advancement and commercial distribution of health-related innovations, positioning Shangya Technology as a contributor to the region’s evolving biotech landscape.

SectorHealthcare
IndustryDrug Manufacturers - General
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$154.74MRevenue
0.00Shares Out
0Employees

Margins

30.02%Gross
-31.19%EBITDA
-47.76%Operating
-61.99%Pre-Tax
-59.78%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

22.02%Rev 3Yr
2.33%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-9.97%ROA
-13.04%ROE
-9.88%ROIC

Financial Health

NT$187.59MCash & Cash Equivalents
NT$39.45MNet Debt
34.89%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Shangya Technology Co., Ltd. (ticker: 6130) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - General).

The current price is 24.65 with a P/E ratio of -x and P/B of -x.

ROE is -13.04% and operating margin is -47.76%. Annual revenue is $155M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Shangya Technology Co., Ltd. (6130) Stock Forecast 2026 $24.65 — Price, Financials & Analyst Targets | Alpha Lenz